DiaZist, located in Tehran (Iran), was founded in 2019. Since its inception, the company has dedicated itself to the production of extremely reliable in vitro diagnostic products with an excellent record of accomplishment in performance, reproducibility and sensitivity. DiaZist products can be used with confidence in diagnosis and monitoring across a variety of domains including, fertility and production, thyroid issues, infectious disorders, cancer and screening of metabolic disorders for neonates. DiaZist products are designed for manual use as well as for application on open automated system. The high quality system is certified according to ISO13485:2016. We will remain committed in our efforts to deliver quality and we continue to use our resources to develop new, innovative products that aid healthcare professionals in the treatment of human disease.